M87.12

⚠ Non-billable (Header)

Osteonecrosis due to drugs, humerus

Diseases of the musculoskeletal system and connective tissue (M00-M99)

⚠️ This is a category header code — not billable. Use a more specific child code below.

Check This Code

❌ Excludes1

inherited

Rules inherited from parent codes in the hierarchy.

  • juvenile osteonecrosis (M91-M92)
  • osteochondropathies (M90-M93)

📋 Code Instructions

inherited
  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
  • code to identify major osseous defect, if applicable (M89.7-)

Clinical Description

ICD-10-CM code M87.12 represents osteonecrosis due to drugs, humerus. This code falls under the Diseases of the musculoskeletal system and connective tissue (M00-M99) classification. It is a non-billable category header code. A more specific child code from the list below must be used for billing and reimbursement purposes.

This is a 6-character code at the 5th level of specificity. There are 3 more specific child codes under M87.12. Coders should note that M87.12 has 2 Excludes1 restriction(s) — codes that cannot be reported together on the same claim.

Frequently Asked Questions

What is ICD-10 code M87.12?

ICD-10-CM code M87.12 is "Osteonecrosis due to drugs, humerus". It belongs to the category: Diseases of the musculoskeletal system and connective tissue (M00-M99).

Is M87.12 a billable ICD-10 code?

No, M87.12 is a non-billable header code. A more specific child code must be used for billing.

What codes are excluded with M87.12?

M87.12 has 2 Excludes1 rule(s). These codes are mutually exclusive and cannot be coded together on the same claim.

🧪 Validate Combinations

Add M87.12 to the Excludes Checker to validate against your full code list.

Open in Checker →

Code Information

CodeM87.12
BillableNo — Header code
ParentM87.1
CategoryDiseases of the musculoskeletal system and connective tissue (M00-M99)
Excludes12 rule(s)
Excludes20 note(s)
Child codes3

Data Source

CMS ICD-10-CM 2026 Tabular List

Updated October 1, 2025 (FY2026)